FLT3LG and neoplasm: Therefore, these cells might also play a role in the immunosuppressive TME, nonetheless, the lack of increase in pDCs in the TS/A tumor model would suggest that pDCs are not the major contributing factor preventing an anti-tumor effect of Flt3L therapy and other mechanisms are also at play.